Factors determining quality of plasma

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 507-511

  Myllylä, Gunnar ^a  

^a Finnish Red Cross   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 8 CONCENTRATE; IMMUNOGLOBULIN;

BLOOD SAMPLING; BLOOD STORAGE; CONFERENCE PAPER; PLASMA; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0031854059     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05466.x     Document Type: Conference Paper

References (11)

1. Myllylä G: Whole blood and plasma producrement and the impact of plasmapheresis.In: R.J. Harris (ed.): Blood Separation and Plasma Fractionation, John Wiley & Sons, New York, 1991, pp. 15-42.
2. Carlebjörk G, Blombäck M, Blomstedt M, Åkerblom O: Screening of Factor VIII:C levels in blood donors. Vox Sang 1986:51:306-309
3. Nilsson IM, Mikaelsson M, Vilhardt H, Walter H: DDAVP factor VIII concenetrate and its properties in vivo and in vitro. Thromb Res 1979;15:263-271.
4. Prowse C, Waterston YG, Dawes J and Farrugia A: Studies on the procurement of blood coagulation Factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant. Vox Sang 1987;52:257-264.
5. Högman CF, Eriksson L, Gong J, Högman AB, Vikholm K, Debrauwere J, Payrat JM and Stewart M: Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use. Vox Sang 1993;65:271-278.
6. Törmä E and Myllylä G: Parameters affecting the fractionation of the F VIII:C activity in production of very high purity AHF concentrate. Scand J Haematol 1984;33:Suppl. 40:123-126
7. Pflugshaupt R, Kurt G: FpA content - a criterion of quality for plasma Factor VIII source. Vox Sang 1983;45:224-232.
8. Hughes C, Thomas KB, Shiff P, Herrington RW, Polacsek EE and McGrath KM. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate. Transfusion 1988;28:566-570
9. Pietersz RNI, de Korte D, Reesink HW, Deker WJA, Ende A and Loos JA: Storage of whole blood for up 24 hours at ambient temperature prior to component preparation. Vox Sang 1989;56:145-150.
10. Mannucci PM, Lattuada A and Ruggeri ZM: Proteolysis of von Willebrand Factor in therapeutic plasm concentrates. Blood 1994;83:10:3018-3027
11. Farrugia A, Street A, Douglas S, Raines G, Aumann H, Whyte G, Sykes S and Oates A. Stabilization of von Willebrand factor in banked blood by leucocyte depletion. Transfusion Med 1993:3:51-57.